Recombinant genetically engineered bacterium for producing phytosphingosine as well as preparation method and application of recombinant genetically engineered bacterium

By constructing a recombinant genetically engineered strain with high yield of phytosphingosine in Saccharomyces cerevisiae, the problem of low yield of modified phytosphingosine is solved, and efficient and economical production of phytosphingosine is achieved, which is suitable for industrial promotion.

CN118931748AActive Publication Date: 2024-11-12SHANGHAI RECOM BIOTECHNOLOGY CO LTD

Patent Information

Application Number
CN202410967645.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-18
Publication Date
2024-11-12
Estimated Expiration
2044-07-18

AI Technical Summary

Technical Problem

In the prior art, the yield of directly producing phytosphingosine by Saccharomyces cerevisiae modified strains is relatively low, which is difficult to meet the needs of industrial production, and further strain transformation is needed to improve production efficiency.

Method used

By overexpressing serine palmitoyltransferases LCB1, LCB2, tsc3 genes, etc. in the genome of Saccharomyces cerevisiae, and knocking out and inserting specific genes at the same time, recombinant genetically engineered strains with high yield of phytosphingosine were constructed, and the CRISPR Cas9 yeast genome editing method was completed Strain modification.

Benefits of technology

It has achieved high yield of phytosphingosine, and the fermentation 4D output is as high as 0.85g/L. It is economical in cost and simple in process, and is suitable for industrial applications.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118931748A_ABST
    Figure CN118931748A_ABST
Patent Text Reader

Abstract

The invention provides a recombinant genetically engineered bacterium for producing phytosphingosine as well as a preparation method and application of the recombinant genetically engineered bacterium, and belongs to the technical field of gene recombinant fermentation. The recombinant genetically engineered bacterium is prepared by overexpressing a serine palmitoyl transferase LCB1 gene, a serine palmitoyl transferase LCB2 gene, a serine palmitoyl transferase tsc3 gene, a 3-dehydrodihydrosphingosine reductase tsc10 gene, a sphingosine hydroxylase sur2 gene, a serine integratin tms1 gene and a phosphoglycerate dehydrogenase ser3 gene in a genome of the saccharomyces cerevisiae. A sphingosine kinase phosphate LCB4 gene, a ceramide synthase LAG1 gene, a ceramide synthase LAC1 gene, an LDB16 gene, a sphingolipid homeostasis protein orm1 gene, a sphingolipid homeostasis protein orm2 gene, an L-serine deaminase CHA1 gene, an L-serine hydroxymethyltransferase SHM1 gene, an L-serine hydroxymethyltransferase SHM2 gene and a fatty acid elongase elo2 gene are knocked out to obtain the gene. The method for producing the phytosphingosine by using the recombinant genetically engineered bacterium is economical in cost, simple and efficient in process, high in yield of the phytosphingosine, and suitable for practical popularization and application.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of gene recombination fermentation, and specifically relates to a recombinant genetic engineering bacterium producing phytosphingosine, a preparation method and application thereof. Background Art

[0002] Sphingolipids are lipid substances composed of two major groups, fatty acids and sphingosine. According to the different coupling side chains, they are mainly divided into ceramides, sphingomyelins, sphingolipids and other types. Among them, ceramide can form a mesh structure in the stratum corneum to maintain skin moisture. Ceramide with phytosphingosine as the base chain is the easiest to lose. However, phytosphingosine is a key precursor of ceramide in moisturizing skin care products. Therefore, the cosmetics industry prefers to add ceramides of phytosphingosine to develop a variety of popular commercial application products.

[0003] At present, phytosphingosine has been approved by the State Food and Drug Administration and is widely added to high-end skin care products. However, phytosphingosine is mainly distributed in seeds of plants such as wheat. Its content is very small and its extraction is extremely difficult. It is known as "soft gold of plants". When extracting phytosphingosine from plant seeds, it is difficult to purify and the yield is low, which is difficult to meet the current market demand.

[0004] Another method of producing phytosphingosine is to synthesize phytosphingosine by microbial synthesis. The cost of synthesizing phytosphingosine by microbial synthesis is lower, the cycle is shorter, and most importantly, its raw materials are easier to obtain. In 1956, when isolating the haploid of the non-model strain Pichia ciferrii (Wickham's yeast), it was unexpectedly discovered that it can produce the acetylated product of phytosphingosine - Tetraacetyl phytosphingosine (TAPS). However, tetraacetyl phytosphingosine needs to be deacetylated by alkaline method to obtain phytosphingosine.

[0005] At present, phytosphingosine can be directly synthesized by fermentation of bacterial strains. For example, the U.S. patent application with publication number US20180179562 records the synthesis of phytosphingosine in Saccharomyces cerevisiae, and the shake flask yield reaches 70 mg / L. The Chinese patent application with publication number CN116103176A records that by genetically modifying the Saccharomyces cerevisiae strain, the final 5L fermentation tank phytosphingosine production reached 2.817 g / L. Therefore, the simple method of obtaining phytosphingosine by direct fermentation of microorganisms will become the preferred method for large-scale production of phytosphingosine in the future.

[0006] However, the prior art records that the production of phytosphingosine by using modified strains of Saccharomyces cerevisiae directly has a relatively low yield, which is not suitable for industrial production and needs further strain modification. Therefore, it is necessary to study strains with better phytosphingosine production effects. Summary of the invention

[0007] The purpose of the present invention is to provide a recombinant genetic engineering bacterium producing phytosphingosine and a preparation method and use thereof.

[0008] The invention provides a recombinant genetic engineering bacterium for producing phytosphingosine. The recombinant genetic engineering bacterium is obtained by overexpressing serine palmitoyltransferase LCB1 gene, LCB2 gene, tsc3 gene, 3-dehydrodihydrosphingosine reductase tsc10 gene, sphingosine hydroxylase sur2 gene, serine integrin tms1 gene, phosphoglycerate dehydrogenase ser3 gene in the genome of saccharomyces cerevisiae, and knocking out sphingosine kinase phosphate LCB4 gene, ceramide synthase LAG1 gene and LAC1 gene, LDB16 gene, sphingolipid homeostasis protein orm1 gene and orm2 gene, L-serine deaminase CHA1 gene, L-serine hydroxymethyltransferase SHM1 gene and SHM2 gene, and fatty acid elongase elo2 gene.

[0009] Furthermore, the aforementioned recombinant genetically engineered bacteria simultaneously insert an expression cassette of the serine palmitoyltransferase LCB1 gene and an expression cassette of the LCB2 gene at the site where the LCB4 gene and the orm2 gene are knocked out in the genome of Saccharomyces cerevisiae, an expression cassette of the tsc3 gene and an expression cassette of the 3-dehydrodihydrosphingosine reductase tsc10 gene are inserted at the site where the LAG1 gene is knocked out, an expression cassette of the sphingosine hydroxylase sur2 gene is inserted at the site where the LAC1 gene is knocked out, and an expression cassette of the phosphoglycerate dehydrogenase ser3 gene and an expression cassette of the serine integrin tms1 gene are inserted at the site where the elo2 gene is knocked out.

[0010] Furthermore, the expression cassette of the serine palmitoyltransferase LCB1 gene includes a Gal10 promoter, a serine palmitoyltransferase LCB1 gene, and a CYC1 terminator; the expression cassette of the serine palmitoyltransferase LCB2 gene includes a Gal1 promoter, a serine palmitoyltransferase LCB2 gene, and a TEF1 terminator; the expression cassette of the tsc3 gene includes a Gal10 promoter, a tsc3 gene, and a CYC1 terminator; the expression cassette of the 3-dehydrosphingosine reductase tsc10 gene includes a Gal10 promoter, a tsc3 gene, and a CYC1 terminator; 1 promoter, 3-dehydrodihydrosphingosine reductase tsc10 gene and TEF1 terminator, the expression cassette of sphingosine hydroxylase sur2 gene includes Gal1 promoter, sphingosine hydroxylase sur2 gene and TEF1 terminator, the expression cassette of phosphoglycerate dehydrogenase ser3 gene includes Gal1 promoter, phosphoglycerate dehydrogenase ser3 gene and TEF1 terminator, the expression cassette of serine integrin tms1 gene includes Gal10 promoter, serine integrin tms1 gene and CYC1 terminator;

[0011] The nucleotide sequence of the Gal1 promoter is shown in SEQ ID NO: 1, the nucleotide sequence of the Gal10 promoter is shown in SEQ ID NO: 2, the nucleotide sequence of the CYC1 terminator is shown in SEQ ID NO: 3, and the nucleotide sequence of the TEF1 terminator is shown in SEQ ID NO: 4.

[0012] Furthermore, the serine palmitoyltransferase LCB1 gene, LCB2 gene, tsc3 gene, 3-dehydrosphingosine reductase tsc10 gene, sphingosine hydroxylase sur2 gene, serine integrin tms1 gene, and phosphoglycerate dehydrogenase ser3 gene are all from Saccharomyces cerevisiae S288c.

[0013] Furthermore, the recombinant genetically engineered bacteria does not contain the following genes: sphingosine kinase phosphate LCB4 gene, ceramide synthase LAG1 gene and LAC1 gene, LDB16 gene, sphingolipid homeostasis protein orm1 gene and orm2 gene, L-serine deaminase CHA1 gene, L-serine hydroxymethyltransferase SHM1 gene and SHM2 gene, fatty acid elongase elo2 gene.

[0014] Further, the sphingosine kinase phosphate LCB4 gene (NCBI-GeneID: 854342), sphingolipid homeostasis protein orm2 gene (NCBI-GeneID: 851064), serine palmitoyltransferase LCB1 gene (NCBI-GeneID: 855342) and LCB2 gene (NCBI-GeneID: 851634), ceramide synthase LAG1 gene (NCBI-GeneID: 856386) and LAC1 gene (NCBI-GeneID: 853861), tsc3 gene (NCBI- The expression cassettes of the 3-dehydrosphingosine reductase tsc10 gene (NCBI-GeneID:852568), the sphingosine hydroxylase sur2 gene (NCBI-GeneID:851891), the fatty acid elongase elo2 gene (NCBI-GeneID:850400), the phosphoglycerate dehydrogenase ser3 gene (NCBI-GeneID:856814) and the serine integrin tms1 gene (NCBI-GeneID:851682) are all from Saccharomyces cerevisiae S288c.

[0015] Furthermore, the recombinant genetically engineered bacteria do not contain the following genes: sphingosine kinase phosphate LCB4 gene, ceramide synthase LAG1 gene and LAC1 gene, LDB16 gene, sphingolipid homeostasis protein orm1 gene (NCBI-GeneID: 852926) and orm2 gene, L-serine deaminase CHA1 gene (NCBI-GeneID: 850295), L-serine hydroxymethyltransferase SHM1 gene (NCBI-GeneID: 852565) and SHM2 gene (NCBI-GeneID: 850747), fatty acid elongase elo2 gene;

[0016] Furthermore, the sphingosine kinase phosphate LCB4 gene, ceramide synthase LAG1 gene and LAC1 gene, LDB16 gene, sphingolipid homeostasis protein orm1 gene and orm2 gene, L-serine deaminase CHA1 gene, L-serine hydroxymethyltransferase SHM1 gene and SHM2 gene, and fatty acid elongase elo2 gene are all from Saccharomyces cerevisiae S288c.

[0017] Furthermore, the brewer's yeast is brewer's yeast S288c.

[0018] Furthermore, the brewer's yeast S288c is obtained from soil screening.

[0019] Furthermore, the transformation of the recombinant genetically engineered bacteria is accomplished using the CRISPR Cas9 yeast genome editing method.

[0020] The present invention also provides the use of the aforementioned recombinant genetic engineering bacteria in producing phytosphingosine.

[0021] The present invention also provides a method for producing phytosphingosine, which comprises the following steps:

[0022] The aforementioned recombinant genetic engineering strain is inoculated into a YPD seed medium, cultured overnight at 25-30° C. and 100-200 rpm, transferred to a YPD fermentation medium, fermented for 4-10 days at 25-30° C. and 100-200 rpm, and after the fermentation is completed, the bacterial cells are collected by centrifugation, ground and crushed, and then extracted with methanol to obtain phytosphingosine;

[0023] The seed culture medium and fermentation liquid are formulated as follows: 15-20 g / L of peptone, 5-10 g / L of yeast powder, 10-30 g / L of glucose, and the balance is water.

[0024] Furthermore, the formula of the seeds and fermentation medium is: 20 g / L peptone, 10 g / L yeast powder, 20 g / L glucose, and the balance is water.

[0025] Gal1 nucleotide sequence (SEQ ID NO: 1):

[0026] TGTGCCTCGCGCCGCACTGCTCCGAACAATAAAGATTCTACAATACTAGCTTTTATGGGTTATGAAGAGGAAAAATTGGCAGTAACCTGGCCCCACAAACCTTCAAATGAACGAATCAAATTAACAACCATAGGATGATAATGCGATTAGTTTTTTAGCCTTATTTCTGGGGTAATTA ATCACGAAGCGATGATTTTTGATCTATTAACAGATATATAAATGCAAAAACTGCATAACCACTTTAACTAATACTTTCAACATTTTCGGTTTGTATTACTTCTTATTCAAATGTAATAAAAGTATCAACAAAAAATTGTTAATATACCTCTATACTTTAACGTCAAGGAGAAAAAAC

[0027] Gal10 nucleotide sequence (SEQ ID NO: 2):

[0028] TTTTCAAAAATTCTTACTTTTTTTTTGGATGGACGCAAAGAAGTTTAATAATCATATTACATGGCATTACCACCATATACATATCCATATACATATCCATATCTAATCTTACTTATATGTTGTGGAAATGTAAAGAGCCCCATTATCTTAGCCTAAAAAAACCTTCTCTTTGGAACTTTCAGTAATACGCTTAACTGCTCATTGCTATATTGAAGTACGGATTAGAAGCCGCCGAGCGGGTGACAGCCCTCCGAAGGAAGACTCTCCTCCGTGCGTCCTCGTCTTCACCGGTCGCGTTCCTGAAACGCAGA

[0029] CYC1 terminator nucleotide sequence (SEQ ID NO:3):

[0030] ATCCGCTCTAACCGAAAAGGAAGGAGTTAGACAACCTGAAGTCTAGGTCCCTATTTATTTTTTTATAGTTATGTTAGTATTAAGAACGTTATTTATATTTCAAATTTTTCTTTTTTTTCTGTACAGACGCGTGTACGCATGTAACATTATACTGAAAACCTTGCTTGAGAAGGTTTTGGGACGCTCGAAG

[0031] TEF1 terminator nucleotide sequence (SEQ ID NO:4):

[0032] CTGAATTGGAGCGACCTCATGCTATACCTGAGAAAGCAACCTGACCTACAGGAAAGAGTTACTCAAGAATAAGAATTTTCGTTTTAAAACCTAAGAGTCACTTTAAAATTTGTATACACTTATTTTTTTTATAACTTATTTAATAATAAAAATCATAAATCATAAGAAATTCGCTTATTTAGAAGTGTCAACAACGTATCTACCAACGATTTGACCCTTTTCCATCTTTTCGTAAATTTCTGGCAAGGTAGACAAGCCGACAACCTTGATTGGAGACTTGACCAAACCTCTGGCGAAGAATT

[0033] The present invention realizes the synthesis of sphingolipid derivatives such as phytosphingosine in the model organism Saccharomyces cerevisiae, including overexpression of key synthesis pathways, knockdown of precursor serine degradation pathways and increase of its flux, knockout of key genes in the phytosphingosine degradation pathway, etc., thereby obtaining an engineered strain with high intracellular phytosphingosine production.

[0034] Compared with the prior art, the present invention has the following beneficial effects:

[0035] The invention provides a recombinant genetically engineered bacterium producing phytosphingosine. The method for producing phytosphingosine by using the recombinant genetically engineered bacterium is cost-effective, simple in process and efficient, and has a high yield of phytosphingosine (the yield after 4 days of fermentation is as high as 0.85 g / L), which is suitable for practical promotion and application.

[0036] Obviously, according to the above contents of the present invention, in accordance with common technical knowledge and customary means in the art, without departing from the above basic technical ideas of the present invention, other various forms of modification, replacement or change may be made.

[0037] The above contents of the present invention are further described in detail below through specific implementation methods in the form of embodiments. However, this should not be understood as the scope of the above subject matter of the present invention being limited to the following examples. All technologies realized based on the above contents of the present invention belong to the scope of the present invention. BRIEF DESCRIPTION OF THE DRAWINGS

[0038] Figure 1 Metabolic diagram of phytosphingosine biosynthesis.

[0039] Figure 2 The results of phytosphingosine content in each recombinant Saccharomyces cerevisiae engineered strain after 4 days of fermentation. DETAILED DESCRIPTION

[0040] Unless otherwise specified, the raw materials and equipment used in the specific embodiments of the present invention are all known products and are obtained by purchasing commercially available products.

[0041] The Saccharomyces cerevisiae used in the present invention is Saccharomyces cerevisiae S288c.

[0042] Example 1: Construction of recombinant genetically engineered bacteria producing phytosphingosine

[0043] The steps of constructing recombinant genetically engineered bacteria in this embodiment are as follows:

[0044] (1) The Crispr Cas9 knockout system was used to edit the sphingosine kinase phosphate LCB4 gene, ceramide synthase LAG1 gene and LAC1 gene in the Saccharomyces cerevisiae genome. The corresponding p426 linear fragment with 20 bp sgRNA was amplified by PCR using primers p426-LCB4-F / P426-R, p426-LAG1-F / P426-R, and p426-LAC1-F / P426-R, all with p426 vector as template (purchased from addgene, catalog number #68060); the three PCR products were detected by 1.0% agarose gel electrophoresis and purified with a clean-up kit; the three recovered DNAs were transformed into E. coli DH5a, and obtain the transformation product; the transformation product was spread on LB solid medium (containing final concentration of 100 mg / L ampicillin), and the plasmid was extracted for sequencing verification after shaking flask culture at 37°C and 220 rpm for 12-16 hours. The verification primer was P426yz-1, and then the recombinant plasmids p426-sgRNA-LCB4, p426-sgRNA-LAG1 and p426-sgRNA-LAC1 were obtained after verification, wherein the 20 bp sgRNA nucleotide sequence in p426-sgRNA-LCB4 is shown in the italicized bold part of the primer p426-LCB4-F; the 20 bp in p426-sgRNA-LAG1 The sgRNA nucleotide sequence is shown in the italic bold portion of the primer p426-LAG1-F; the 20bp sgRNA nucleotide sequence in p426-sgRNA-LAC1 is shown in the italic bold portion of the primer p426-LAC1-F. The corresponding primers are listed in Table 1.

[0045] (2) In order to construct the Donor fragment, the Saccharomyces cerevisiae genome was used as a template, and the corresponding LCB4 gene, LAG1 gene, and upper and lower 500 bp homology arm fragments of the LAC1 gene were amplified by PCR using primers LCB4-upF / LCB4-upR, LCB4-downF / LCB4-downR, LAG1-upF / LAG1-upR, LAG1-downF / LAG1-downR, LAC1-upF / LAC1-upR, and LAC1-downF / LAC1-downR, respectively; the six PCR products were detected by 1.0% agarose gel electrophoresis and purified with a clean-up kit. The corresponding primers are listed in Table 1.

[0046] (3) Construction of a Saccharomyces cerevisiae strain containing the P414-cas9 vector; a small amount of the Saccharomyces cerevisiae S288c stored in a glycerol tube was streaked onto a YPD solid plate using an inoculation stick and placed in a 30°C incubator for 48 h; a single colony was picked and inoculated into 5 mL of YPD liquid culture medium and placed in an incubator at 30°C and 200 rpm for overnight culture until the OD 600 The pH value was 0.8-1; the culture medium was taken out, and a commercial yeast preparation competent state kit (purchased from Zymo Research, product number T2001) was used to prepare a Saccharomyces cerevisiae competent state; then P414-cas9 (purchased from Addgene, product number #43802) was transformed into a Saccharomyces cerevisiae competent state, placed at 30°C, 200rpm shaking incubator for 3h, spread onto SC-trp solid culture medium, placed at 30°C incubator for 48h, and a Saccharomyces cerevisiae strain containing the P414-cas9 vector was obtained.

[0047] (4) The Saccharomyces cerevisiae strain containing the P414-cas9 vector was cultured in SC-trp medium at 30°C overnight until OD 600When the p426-sgRNA and the corresponding Donor (upper and lower homologous arms + expression cassette of inserted gene) prepared above are added to the competent state, and then solution 3 in the kit is added, and cultured at 30℃200rpm for 1h, and then coated on SC-trp-ura double-deficient culture dishes (the SC-trp-ura powder was purchased from Panjinuo, item number YGM003A-31), and cultured at 30℃ for 48h. Several single colonies were picked from the plate as templates, and PCR was performed with the corresponding verification primers (the corresponding primers LCB4YZ-1 / LCB4-downR, LAC1YZ-1 / LAC1-downR and LAG1YZ-1 / LAG1-downR in Table 1), and the gene deletion was confirmed by observing whether there was a correct DNA band in 1.0% agarose gel. The strain in which the gene encoding sphingosine kinase phosphate LCB4, ceramide synthase LAG1 and LAC1 had been successfully knocked out was inoculated into 5 mL of YPD liquid culture medium and placed in a 30°C incubator for overnight culture. The culture solution was then spread or streaked onto an SC-trp plate containing 5FOA (the SC-trp powder was purchased from Panjinuo, catalog number YGM003A-2). The single colonies that grew out were again verified on SC-ura (the SC-ura powder was purchased from Panjinuo, catalog number YGM003A-3) to verify whether the p426-sgRNA vector had been removed. If no plasmid grows on SC-ura, it means the plasmid has been eliminated. Finally, the p414-cas9 plasmid is eliminated by self-passage, and the plasmid from which the p426-sgRNA plasmid has been eliminated is inoculated into YPD medium for overnight culture, and then streaked onto YPD plates for culture for 24-48 hours. The corresponding single colonies are verified on the plates. As long as the single colony does not grow on the SC-trp-ura double-deficient medium, it is the target strain that has successfully knocked out the two plasmids.

[0048] (5) According to the above-mentioned gene knockout steps, the LCB4 gene, LAG1 gene and LAC1 gene were knocked out in the genome in turn. The strains constructed in this way were recorded as Saccharomyces cerevisiae Sc△LCB4 (abbreviated as Sc01), Sc△LCB4△LAG1 (abbreviated as Sc02) and Sc△LCB4△LAG1△LAC1 (abbreviated as Sc03).

[0049] Example 2: Preparation and determination of phytosphingosine

[0050] (I) Preparation method

[0051] Take the three recombinant Saccharomyces cerevisiae engineered strains constructed in Example 1 and the control strain (i.e., the starting strain S.cerevisiae S288c) and inoculate them into YPD seed culture medium for culture, and culture them in a shaking incubator at 30°C and 200rpm for 12 to 16 hours to obtain seed liquid; transfer them to 50mL YPD fermentation medium for fermentation at 2% (v / v), and culture them in a shaking incubator at 30°C and 200rpm for 4 days. After the fermentation is completed, the fermentation broth is centrifuged, the supernatant is removed, 10mL of methanol is added, and then the broth is ground and crushed to obtain phytosphingosine. Fermentation process Phytosphingosine synthesis and metabolism process see Figure 1 .

[0052] The formula of YPD fermentation medium is: 20 g / L trypsin, 10 g / L yeast powder, 20 g / L glucose, and the balance is water.

[0053] (II) Determination of phytosphingosine

[0054] Standard sample preparation: prepare 10 g / L phytosphingosine standard sample, dilute it into concentrations of 0.5, 1, 2, 4, and 6 g / L respectively, and pass 1 mL through the membrane for testing.

[0055] Sample preparation: Take 1mL of fermentation liquid and centrifuge it at 12000rpm for 5min, remove the supernatant, add 1mL of methanol, and then add an appropriate amount of white zirconium beads, use a crushing instrument to crush, after crushing, centrifuge at 12000rpm for 5min, and take the methanol supernatant for testing.

[0056] LC-MS detection method: LC part: Agilent 1260DAD detector; Agilent SB-C 18 (2.1mm*50mm, 1.8μm) chromatographic column; mobile phase A: 0.1% TFA aqueous solution 30% and mobile phase B: acetonitrile 70% isocratic elution; MS part: ESI ion source, SIM scanning mode, positive ion mode.

[0057] Detect the content of phytosphingosine in the fermentation broth obtained by recombinant fermentation of each recombinant Saccharomyces cerevisiae engineered strain. Figure 2 .Depend on Figure 2 It can be seen that after 4 days of shake flask fermentation, the yields of the three recombinant bacteria were found to be higher than those of the control strain S.cerevisiae S288c (no phytosphingosine was detected in the control strain), among which the strain Sc03 had the highest yield of 0.051 g / L. The above results show that blocking the degradation pathway of intermediate products and phytosphingosine is conducive to the accumulation of phytosphingosine; however, the final phytosphingosine accumulation yield is still very low, which may be related to the weak metabolic flux of the main pathway.

[0058] Example 3: Construction of recombinant genetically engineered bacteria producing phytosphingosine

[0059] The steps of constructing recombinant genetically engineered bacteria in this embodiment are as follows:

[0060] (1) The Crispr Cas9 knockout gene system was used to integrate the LCB1 gene, LCB2 gene, tsc3 gene, tsc10 gene and sur2 gene into the genome of the initial strain of Saccharomyces cerevisiae S288c. The selected insertion sites were the knockout sites of the three genes (LCB4, LAG1, LAC1) in Example 1, and the corresponding p426-sgRNA used was the same as that shown in Example 1.

[0061] (2) In order to construct the Dnonr fragment, the Saccharomyces cerevisiae genome was used as a template and PCR was performed with primers LCB1-F / LCB1-R, LCB2-F / LCB2-R, tsc3-F / tsc3-R, tsc10-F / tsc10-R, and sur2-F / sur2-R to amplify the fragments LCB1, LCB2, tsc3, tsc10, and sur2, respectively; then the five PCR products were detected by 1.0% agarose gel electrophoresis and purified using a clean-up kit.

[0062] Finally, the purified LCB1 fragment and tsc3 fragment were cloned in one step with the BBS17 plasmid linearized by primers Gal10-F / Gal10-R (the map of the circular BBS17 plasmid is shown in the Chinese patent application with publication number CN116716196A), and then transformed into E. coli DH5a to obtain the transformation product; the transformation product was spread on LB solid culture medium (containing a final concentration of 100 mg / L ampicillin), and the plasmid was extracted after shaking flask culture at 37°C and 220 rpm for 12-16 hours for sequencing verification. If the verification was correct, the recombinant plasmids BBS17-tCYC1-LCB1-pGal10 (abbreviated as BBs17-LCB1) and BBS17-tCYC1-tsc3-pGal10 (abbreviated as BBs17-tsc3) were obtained.

[0063] The three plasmids constructed above (BBs17-LCB1, BBs17-tsc3 and circular BBs17) were used as templates, and primers Gal1-F / Gal1-R were used to PCR amplify the linearized vectors BBs17-LCB1, BBs17-tsc3 and BBs17, which were then cloned with the corresponding fragments LCB2, tsc10 and sur2 one by one and transformed into E. coli. DH5a, and obtain the transformation product; the transformation product was spread on LB solid medium (containing final concentration of 100 mg / L ampicillin), and the plasmid was extracted and sequenced for verification after shaking flask culture at 37°C and 220 rpm for 12-16 hours. If the verification was correct, the recombinant plasmids BBS17-tCYC1-LCB1-pGal10-pGal1-LCB2-tTEF1 (abbreviated as BBs17-LCB12), BBS17-tCYC1-tsc3-pGal10-pGal1-tsc10-tTEF1 (abbreviated as BBs17-tsc3-10) and BBS17-pGa l1-sur2-tTEF1 (abbreviated as BBs17-sur2); finally, the recombinant plasmids BBs17-LCB12, BBs17-tsc3-10 and BBs17-sur2 were PCR amplified using primers TF / TR to obtain fragments tCYC1-LCB1-pGal10-pGal1-LCB2-tTEF1, tCYC1-tsc3-pGal10-pGal1-tsc10-tTEF1 and pGal1-sur2-tTEF1. The three PCR products were detected by 1.0% agarose gel electrophoresis and purified using a clean-up kit.

[0064] At the same time, using the Saccharomyces cerevisiae genome as a template, primers LCB4-upF / LCB4-upR1, LCB4-downF1 / LCB4-downR, LAG1-upF / LAG1-upR1, LAG1-downF1 / LAG1-downR, LAC1-upF / LAC1-upR1 and LAC1-downF1 / LAC1-downR were used to amplify the fragments LCB4, LAG1 and the upper and lower 500bp homology arms of LAC1; the 6 PCR products were detected by 1.0% agarose gel electrophoresis and purified with a clean-up kit. The corresponding primers are listed in Tables 1 and 2.

[0065] (3) The prepared p426-sgRNA and the corresponding Donor (upper and lower homologous arms + expression cassette of the inserted gene) were added to the competent yeast strain containing the P414-cas9 vector (prepared in the same manner as in Example 1), and then solution 3 in the kit was added, cultured at 30°C 200rpm for 1h, and then coated on the SC-trp-ura double-deficient culture dish and cultured at 30°C for 48h. Several single colonies were picked on the plate as templates, and PCR was performed with the corresponding verification primers (the corresponding primers LCB4YZ-1 / LCB4-downR, LAC1YZ-1 / LAC1-downR and LAG1YZ-1 / LAG1-downR in Table 1), and the deletion of the gene was confirmed by observing whether there was a correct DNA band in the 1.0% agarose gel. The strain that had been successfully replaced was removed from the two plasmids p426-sgRNA and p414-cas9 according to the method in Example 1, and finally the target strain with successful knockout of the two plasmids was obtained.

[0066] (4) According to the above gene insertion steps, the expression cassettes of the serine palmitoyltransferase LCB1 gene and the LCB2 gene were inserted into the LCB4 gene locus on the genome of the original strain of Saccharomyces cerevisiae, the expression cassettes of the tsc3 gene and the 3-dehydrodihydrosphingosine reductase tsc10 gene were inserted into the LAG1 gene locus, and the expression cassette of the sphingosine hydroxylase sur2 gene was inserted into the LAC1 gene locus. The recombinant strains finally obtained were Sc△LCB4::tCYC1-LCB1-pGal10-pGal1-LCB2-tTEF1△LAG1::tCYC1-tsc3-pGal10-pGal1-tsc10-tTEF1△LAC1::pGal1-sur2-tTEF1 (abbreviated as Sc04).

[0067] (5) The Crispr Cas9 knockout system was used to edit the orm1 and orm2 genes encoding the sphingolipid homeostasis proteins and the LDB16 gene in the Saccharomyces cerevisiae genome. The corresponding p426 linear fragments with 20 bps gRNA were amplified by PCR using primers p426-orm1-F / P426-R, p426-orm2-F / P426-R, and p426-LDB16-F / P426-R, all with the p426 vector as a template; the three PCR products were detected by 1.0% agarose gel electrophoresis and purified with a clean-up kit; the three recovered DNAs were transformed into E. coli DH5a, and obtain the transformation product; the transformation product is spread on LB solid medium (containing final concentration of 100 mg / L ampicillin), and the plasmid is extracted for sequencing verification after shaking flask culture at 37°C and 220 rpm for 12-16 hours. If the verification is correct, the recombinant plasmids p426-sgRNA-orm1, p426-sgRNA-orm2 and p426-sgRNA-LDB16 are obtained, wherein the 20 bp sgRNA nucleotide sequence in p426-sgRNA-orm1 is shown in the italic bold portion of primer p426-orm1-F; the 20 bp sgRNA nucleotide sequence in p426-sgRNA-orm2 is shown in the italic bold portion of primer p426-orm2-F; and the 20 bp sgRNA nucleotide sequence in p426-sgRNA-LDB16 is shown in the italic bold portion of primer p426-LDB16-F. The corresponding primers are listed in Tables 1 and 2.

[0068] (6) In order to construct the Donor fragment, the Saccharomyces cerevisiae genome was used as a template, and the primers orm1-upF / orm1-upR, orm1-downF / orm1-downR, orm2-upF / orm2-upR, orm2-downF / orm2-downR, LDB16-upF / LDB16-upR, and LDB16-downF / LDB16-downR were used to amplify the upper and lower 500 bp homology arm fragments of the corresponding orm1 gene, orm2 gene, and LDB16 gene respectively by PCR; the six PCR products were detected by 1.0% agarose gel electrophoresis and purified with a clean-up kit. The corresponding primers are listed in Table 2.

[0069] (7) The same knockout and screening method as in Example 1 was used to knock out the orm1 gene, orm2 gene, and LDB16 gene in the genome of strain Sc04 in sequence according to the above-mentioned gene knockout steps. The strains constructed in this way were recorded as Saccharomyces cerevisiae Sc04△orm1 (abbreviated as Sc05), Sc04△orm1△orm2 (abbreviated as Sc06), and Sc04△orm1△orm2△LDB16 (abbreviated as Sc07).

[0070] Example 4. Preparation and determination of phytosphingosine

[0071] (I) Preparation method

[0072] Take the four recombinant Saccharomyces cerevisiae engineered strains (Sc04, Sc05, Sc06, Sc07) constructed in Example 3 and the control strain (Sc03), inoculate them into YPD seed medium for culture (the medium components are the same as in Example 2), shake and culture at 30°C and 200rpm for 12 to 16h to obtain seed liquid; transfer to YPD fermentation medium for fermentation at 2% (v / v), and place at 30°C and 200rpm for 4d. After the fermentation is completed, the fermentation liquid is centrifuged, the supernatant is removed, and 10mL of methanol is added and ground to obtain phytosphingosine.

[0073] (II) Determination of phytosphingosine

[0074] The detection and determination methods are the same as those in Example 2, except that the brewing engineering strains are 4 brewing yeast engineering strains constructed in this example and the control strain Sc03; the content of phytosphingosine in the fermentation broth obtained by recombinant fermentation of each recombinant brewing yeast engineering strain is detected as follows: Figure 2 .Depend on Figure 2 It can be seen that after 4 days of shake flask fermentation, the maximum yield of the constructed Sc07 was found to be 0.24 g / L. The above results show that enhancing the expression of key enzymes related to the main pathway is beneficial to the accumulation of the target product; Figure 2 It can be seen that the Sc07 yield was further improved from 0.051g / L to 0.24g / L.

[0075] Example 5: Construction of recombinant genetically engineered bacteria producing phytosphingosine

[0076] The steps of constructing recombinant genetically engineered bacteria in this embodiment are as follows:

[0077] (1) The Crispr Cas9 knockout gene system was used for genomic gene integration, and multiple copies of LCB1 and LCB2 were inserted. The insertion sites were the knockout sites of the two genes (orm2 and LDB16) in Example 3, and the corresponding P426-sgRNA used was the same as that shown in Example 3.

[0078] (2) In order to construct the Dnonr fragment, plasmid BBs17-LCB12 was used as a template and primers TF / TR were used to amplify the fragment tCYC1-LCB1-pGal10-pGal1-LCB2-tTEF1; the PCR product was then detected by 1.0% agarose gel electrophoresis and purified with a clean-up kit for later use.

[0079] At the same time, using the Saccharomyces cerevisiae genome as a template, primers orm2-upF / orm2-upR1, orm2-downF1 / orm2-downR, LDB16-upF / LDB16-upR1 and LDB16-downF1 / LDB16-downR were used to amplify the upper and lower 500 bp homology arms of fragments orm2 and LDB16 respectively; the four PCR products were detected by 1.0% agarose gel electrophoresis and purified with a clean-up kit. The corresponding primers are listed in Table 2.

[0080] (3) The prepared p426-sgRNA and the corresponding Donor (upper and lower homologous arms + expression cassette of the inserted gene) were added to the competent yeast strain containing the P414-cas9 vector (prepared in the same manner as in Example 1), and then solution 3 in the kit was added, cultured at 30°C 200rpm for 1h, and then coated on the SC-trp-ura double-deficient culture dish and cultured at 30°C for 48h. Several single colonies were picked on the plate as templates, and PCR was performed with the corresponding verification primers (the corresponding primers Orm2yz-1 / orm2-downR and LDB16YZ-1 / LDB16-downR in Table 2), and the deletion of the gene was confirmed by observing whether there was a correct DNA band in the 1.0% agarose gel. The strain that had been successfully replaced was removed from the two plasmids p426-sgRNA and p414-cas9 according to the method in Example 1, and finally the target strain with successful knockout of the two plasmids was obtained.

[0081] (4) According to the above gene insertion steps, the expression cassette of the serine palmitoyltransferase LCB1 gene and the expression cassette of the LCB2 gene were respectively inserted into the orm2 gene and LDB16 gene loci on the Sc07 genome of Saccharomyces cerevisiae. The recombinant strains finally obtained were Sc07△orm2::tCYC1-LCB1-pGal10-pGal1-LCB2-tTEF1 (abbreviated as Sc08) and Sc07△orm2::tCYC1-LCB1-pGal10-pGal1-LCB2-tTEF1

[0082] △LDB16::tCYC1-LCB1-pGal10-pGal1-LCB2-tTEF1 (abbreviated as Sc09).

[0083] Example 6. Preparation and determination of phytosphingosine

[0084] (I) Preparation method

[0085] The two recombinant Saccharomyces cerevisiae engineered strains constructed in Example 5 and the control strain (Sc07) were inoculated into YPD seed medium (the medium components were the same as in Example 2), and cultured at 30°C and 200rpm shaking for 12 to 16 hours to obtain seed liquid; transferred to YPD fermentation medium for fermentation at 2% (v / v), and placed at 30°C and 200rpm shaking for 4 days. After the fermentation was completed, the fermentation liquid was centrifuged, the supernatant was removed, and 10 mL of methanol was added and ground to obtain phytosphingosine.

[0086] (II) Determination of phytosphingosine

[0087] The detection and determination methods are the same as those in Example 2, except that the brewing engineering strains are two brewing yeast engineering strains constructed in this example and the control strain Sc07; the content of phytosphingosine in the fermentation broth obtained by recombinant fermentation is detected as follows: Figure 2 .Depend on Figure 2 It can be seen that after 4 days of shake flask fermentation, it was found that the constructed Sc08 had a higher yield than Sc09, and its yield could reach 0.38g / L; the above results show that moderate expression of LCB1 and LCB2 is beneficial to the metabolic balance in the bacteria, thereby promoting product accumulation.

[0088] Example 7: Construction of recombinant genetically engineered bacteria producing phytosphingosine

[0089] The steps of constructing recombinant genetically engineered bacteria in this embodiment are as follows:

[0090] (1) The Crispr Cas9 knockout system was used to knock out the L-serine deaminase CHA1 gene, L-serine hydroxymethyltransferase SHM1 gene and SHM2 gene, and fatty acid elongase elo2 gene in the Sc08 genome; using the p426 plasmid as a template, the corresponding p426 linear fragments with 20 bp sgRNA were amplified by PCR using primers p426-CHA1-F / P426-R, p426-SHM1-F / P426-R, p426-SHM2-F / P426-R, and p426-elo2-F / P426-R, respectively; the four PCR products were detected by 1.0% agarose gel electrophoresis and purified with a clean-up kit; the four recovered DNAs were transformed into E. coli DH5a, and obtain the transformation product; the transformation product was spread on LB solid medium (containing final concentration of 100 mg / L ampicillin), and the plasmid was extracted for sequencing verification after shaking flask culture at 37°C and 220 rpm for 12-16 hours. If the verification was correct, the recombinant plasmids p426-sgRNA-CHA1, p426-sgRNA-SHM1, p426-sgRNA-SHM2 and p426-sgRNA-elo2 were obtained. The 20 bp sgRNA nucleotide sequence in p426-sgRNA-CHA1 is shown in the italic bold portion of primer p426-CHA1-F; the 20 bp sgRNA nucleotide sequence in p426-sgRNA-SHM1 is shown in the italic bold portion of primer p426-SHM1-F; the 20 bp sgRNA nucleotide sequence in p426-sgRNA-SHM2 is shown in the italic bold portion of primer p426-SHM2-F; the 20 bp sgRNA nucleotide sequence in p426-sgRNA-elo2 is shown in the italic bold portion of primer p426-elo2-F. The corresponding primers are listed in Tables 1 and 3.

[0091] (2) In order to construct the Donor fragment, the Saccharomyces cerevisiae genome was used as a template, and the primers CHA1-upF / CHA1-upR, CHA1-downF / CHA1-downR, SHM1-upF / SHM1-upR, SHM1-downF / SHM1-downR, SHM2-upF / SHM2-upR, SHM2-downF / SHM2-downR, elo2-upF / elo2-upR, and elo2-downF / elo2-downR were used to amplify the upper and lower 500 bp homology arm fragments of the corresponding CHA1 gene, SHM1 gene, SHM2 gene, and elo2 gene respectively by PCR; the 8 PCR products were detected by 1.0% agarose gel electrophoresis and purified with a clean-up kit. The corresponding primers are listed in Table 3.

[0092] (3) The prepared p426-sgRNA and the corresponding Donor (upper and lower homologous arms) were added to the competent yeast strain containing the P414-cas9 vector (prepared in the same manner as in Example 1), and then solution 3 in the kit was added, cultured at 30°C 200rpm for 1h, and then spread on the SC-trp-ura double-deficient culture dish and cultured at 30°C for 48h. Several single colonies were picked from the plate as templates, and PCR was performed with the corresponding verification primers (the corresponding primers CHA1YZ-1 / CHA1-downR, SHM1YZ-1 / SHM1-downR, SHM2YZ-1 / SHM2-downR and elo2yz-1 / elo2-downR in Table 3), and the gene deletion was confirmed by observing whether there was a correct DNA band in the 1.0% agarose gel. The strain that has been successfully replaced was used to remove the two plasmids p426-sgRNA and p414-cas9 according to the method of Example 1, and finally the target strain with successful knockout of the two plasmids was obtained.

[0093] (4) According to the above steps, the L-serine deaminase CHA1 gene, L-serine hydroxymethyltransferase SHM1 gene and SHM2 gene and fatty acid elongase elo2 gene were knocked out in the Saccharomyces cerevisiae Sc08 genome respectively, and the recombinant strains finally obtained were Sc08△CHA1 (abbreviated as Sc10), Sc08△CHA1△SHM1 (abbreviated as Sc11), Sc08△CHA1△SHM1△SHM2 (abbreviated as Sc12) and Sc08△CHA1△SHM1△SHM2△elo2 (abbreviated as Sc13).

[0094] Example 8. Preparation and determination of phytosphingosine

[0095] (I) Preparation method

[0096] The four recombinant Saccharomyces cerevisiae engineered strains constructed in Example 7 and the control strain (Sc08) were inoculated into YPD seed medium for culture (the medium components were the same as those in Example 2), and cultured at 30°C and 200rpm shaking for 12 to 16 hours to obtain seed liquid; the mixture was transferred to YPD fermentation medium for fermentation at 2% (v / v), and placed at 30°C and 200rpm shaking for 4 days. After the fermentation was completed, the fermentation liquid was centrifuged, the supernatant was removed, 10 mL of methanol was added, and the mixture was ground and crushed to obtain phytosphingosine.

[0097] (II) Determination of phytosphingosine

[0098] The detection and determination methods are the same as those in Example 2, except that the brewing engineering strains are the four brewing yeast engineering strains constructed in this example and the control strain Sc08; the content of phytosphingosine in the fermentation broth obtained by recombinant fermentation is detected as follows: Figure 2 .Depend on Figure 2 It can be seen that the strain Sc12 obtained by knocking out CHA1, SHM1 and SHM2 in the serine metabolic pathway had a significantly increased phytosphingosine production to 0.67 g / L after 4 days of shake flask fermentation. The strain Sc13 obtained by further knocking out elo2 further increased the yield, which was 92% higher than the control strain Sc08, reaching 0.73 g / L. The above results indicate that when the metabolic flux of the main pathway is sufficient, the supply of its precursor substances is the key to the production of phytosphingosine.

[0099] Example 9: Construction of recombinant genetically engineered bacteria producing phytosphingosine

[0100] The steps of constructing recombinant genetically engineered bacteria in this embodiment are as follows:

[0101] (1) The Crispr Cas9 knockout gene system was used for genomic gene integration, and the serine integration protein tms1 gene and the phosphoglycerate dehydrogenase ser3 gene were integrated into the Sc13 genome. The insertion site was the elo2 gene knockout site in Example 7, and the corresponding P426-sgRNA used was the same as that shown in Example 7.

[0102] (2) To construct the Dnonr fragment, the Saccharomyces cerevisiae genome was used as a template and PCR was performed using primers ser3-F / ser3-R and tms1-F / tms1-R to amplify the fragments ser3 and tms1, respectively. The two PCR products were then detected by 1.0% agarose gel electrophoresis and purified using a clean-up kit.

[0103] Finally, the purified tms1 fragment was linearized with the BBS17 plasmid (the map of the circular BBS17 plasmid is shown in the Chinese patent application with publication number CN116716196A) using primers Gal10-F / Gal10-R for one-step cloning, and then transformed into E. coli DH5a to obtain a transformation product; the transformation product was spread on LB solid culture medium (containing a final concentration of 100 mg / L ampicillin), and the plasmid was extracted and sequenced for verification after shaking at 37°C and 220 rpm for 12-16 hours. If the verification was correct, the recombinant plasmid BBS17-tCYC1-tms1-pGal10 (abbreviated as BBs17-tms1) was obtained.

[0104] Using BBs17-tms1 as a template, primers Gal1-F / Gal1-R were used to amplify the linearized vector BBs17-tms1, which was then cloned with fragment ser3 in one step and transformed into E. coli. DH5a, and obtain the transformation product; the transformation product was spread on LB solid culture medium (containing final concentration of 100 mg / L ampicillin), and the plasmid was extracted for sequencing verification after shaking flask culture at 37°C and 220 rpm for 12-16 hours. If the verification is correct, the recombinant plasmid BBS17-tCYC1-tms1-pGal10-pGal1-ser3-tTEF1 (abbreviated as BBs17-tsc3-ser3) was obtained; using the above constructed plasmid BBs17-tsc3-ser3 as a template, PCR was performed with primers TF / TR to amplify the fragment tCYC1-tms1-pGal10-pGal1-ser3-tTEF1, and the PCR product was detected by 1.0% agarose gel electrophoresis and purified with a clean-up kit.

[0105] At the same time, the upper and lower 500bp homology arms of the elo2 gene were amplified using the Saccharomyces cerevisiae genome as a template using primers elo2-upF / elo2-upR1 and elo2-downF1 / elo2-downR, respectively; the two PCR products were detected by 1.0% agarose gel electrophoresis and purified using a clean-up kit. The corresponding primers are listed in Tables 2, 3 and 4.

[0106] (3) The prepared p426-sgRNA and the corresponding Donor (upper and lower homologous arms + expression cassette of the inserted gene) were added to the competent Saccharomyces cerevisiae strain containing the P414-cas9 vector (prepared in the same manner as in Example 1), and then solution 3 in the kit was added, cultured at 30°C 200rpm for 1h, and then spread on the SC-trp-ura double-deficient culture dish and cultured at 30°C for 48h. Several single colonies were picked on the plate as templates, and PCR was performed with the corresponding verification primers (the corresponding primers elo2yz-1 / elo2-downR in Table 3), and the deletion of the gene was confirmed by observing whether there was a correct DNA band in the 1.0% agarose gel. The strain that had been successfully replaced was removed from the two plasmids p426-sgRNA and p414-cas9 according to the method of Example 1, and finally the target strain with successful knockout of the two plasmids was obtained.

[0107] (5) According to the above gene insertion steps, the expression cassettes of the serine integrin tms1 gene and the phosphoglycerate dehydrogenase ser3 gene were inserted into the elo2 gene locus on the Sc13 genome of Saccharomyces cerevisiae in sequence, and the recombinant strain finally obtained was Sc13△elo2::tCYC1-tms1-pGal10-pGal1-ser3-tTEF1 (abbreviated as Sc14).

[0108] Example 10. Preparation and determination of phytosphingosine

[0109] (I) Preparation method

[0110] The recombinant cerevisiae engineered strain Sc14 constructed in Example 9 was inoculated into a YPD seed medium (the medium components were the same as in Example 2), and cultured at 30°C and 200rpm on a shaking table for 12 to 16 hours to obtain a seed solution; the solution was transferred to a YPD fermentation medium at 2% (v / v) for fermentation, and placed on a shaking table at 30°C and 200rpm for 4 days. After the fermentation was completed, the fermentation broth was centrifuged, the supernatant was removed, 10 mL of methanol was added, and the broth was ground and crushed to obtain phytosphingosine.

[0111] (II) Determination of phytosphingosine

[0112] The detection and determination methods are the same as those in Example 2, except that the brewing engineering strain is constructed using the brewing engineering strain (Sc14) of Saccharomyces cerevisiae in this example; the content of phytosphingosine in the fermentation broth obtained by recombinant fermentation is detected as follows: Figure 2 .Depend on Figure 2 It can be seen that after 4 days of shake flask fermentation, the production of phytosphingosine reached 0.85 g / L; the above results indicate that increasing the supply of precursor substances is beneficial to the carbon metabolism flow to the production of target products.

[0113] Table 1. Primers used in the experiment

[0114]

[0115]

[0116] Table 2. Primers used in the experiment

[0117]

[0118]

[0119] Table 3. Primers used in the experiment

[0120]

[0121]

[0122] Table 4. Primers used in the experiment

[0123] Primer name Primer sequence (5′-3′) SEQ ID NO: ser3-F CGTCAAGGAGAAAAAACCCCATGACAAGCATTGACATTAA 93 ser3-R AGCTAGCCGCGGTACCAAGC 94 tms1-F GTAAGAATTTTTGAAAATTCATGGGTGCCGTAATTTCTTT 95 tms1-R CATCCTTGTAATCCATCGATTTAATAGTAATTCTCGTAAT 96 elo2-upR1 ATGAGGTCGCTCCAATTCAGGGCTTCTAGACGAAGATAAT 97 elo2-downF1 ATTATCTTCGTCTAGAAGCCCTGAATTGGAGCGACCTCAT 98

[0124] In summary, the present invention provides a recombinant genetically engineered bacterium that produces phytosphingosine. The method for producing phytosphingosine using the recombinant genetically engineered bacterium is cost-effective, simple in process and efficient, and has a high yield of phytosphingosine (the yield after 4 days of fermentation is as high as 0.85 g / L), which is suitable for practical promotion and application.

Claims

1. A recombinant genetically engineered bacterium producing phytosphingosine, characterized in that: It is obtained by overexpressing the serine palmitoyltransferase LCB1 gene, LCB2 gene, tsc3 gene, 3-dehydrodihydrosphingosine reductase tsc10 gene, sphingosine hydroxylase sur2 gene, serine integrin tms1 gene, phosphoglycerate dehydrogenase ser3 gene in the genome of Saccharomyces cerevisiae, and knocking out the sphingosine kinase phosphate LCB4 gene, ceramide synthase LAG1 gene and LAC1 gene, LDB16 gene, sphingolipid homeostasis protein orm1 gene and orm2 gene, L-serine deaminase CHA1 gene, L-serine hydroxymethyltransferase SHM1 gene and SHM2 gene, and fatty acid elongase elo2 gene.

2. The recombinant genetically engineered bacterium according to claim 1, characterized in that: It is a method of inserting an expression cassette of the serine palmitoyltransferase LCB1 gene and an expression cassette of the LCB2 gene at the same time at the site where the LCB4 gene and the orm2 gene are knocked out in the genome of Saccharomyces cerevisiae, inserting an expression cassette of the tsc3 gene and an expression cassette of the 3-dehydrodihydrosphingosine reductase tsc10 gene at the site where the LAG1 gene is knocked out, inserting an expression cassette of the sphingosine hydroxylase sur2 gene at the site where the LAC1 gene is knocked out, and inserting an expression cassette of the phosphoglycerate dehydrogenase ser3 gene and an expression cassette of the serine integrin tms1 gene at the site where the elo2 gene is knocked out.

3. The recombinant genetically engineered bacterium according to claim 2, characterized in that: The expression cassette of the serine palmitoyltransferase LCB1 gene includes a Gal10 promoter, a serine palmitoyltransferase LCB1 gene and a CYC1 terminator, the expression cassette of the serine palmitoyltransferase LCB2 gene includes a Gal1 promoter, a serine palmitoyltransferase LCB2 gene and a TEF1 terminator, the expression cassette of the tsc3 gene includes a Gal10 promoter, a tsc3 gene and a CYC1 terminator, the expression cassette of the 3-dehydrodihydrosphingosine reductase tsc10 gene includes a Gal1 promoter, a tsc3 gene and a CYC1 terminator, The expression cassette of the sphingosine hydroxylase sur2 gene includes the Gal1 promoter, the sphingosine hydroxylase sur2 gene and the TEF1 terminator, the expression cassette of the phosphoglycerate dehydrogenase ser3 gene includes the Gal1 promoter, the phosphoglycerate dehydrogenase ser3 gene and the TEF1 terminator, and the expression cassette of the serine integrin tms1 gene includes the Gal10 promoter, the serine integrin tms1 gene and the CYC1 terminator; The nucleotide sequence of the Gal1 promoter is shown in SEQ ID NO: 1, the nucleotide sequence of the Gal10 promoter is shown in SEQ ID NO: 2, the nucleotide sequence of the CYC1 terminator is shown in SEQ ID NO: 3, and the nucleotide sequence of the TEF1 terminator is shown in SEQ ID NO:

4.

4. The recombinant genetically engineered bacterium according to claim 3, characterized in that: The serine palmitoyltransferase LCB1 gene, LCB2 gene, tsc3 gene, 3-dehydrosphingosine reductase tsc10 gene, sphingosine hydroxylase sur2 gene, serine integrin tms1 gene, and phosphoglycerate dehydrogenase ser3 gene are all from Saccharomyces cerevisiae S288c.

5. The recombinant genetically engineered bacterium according to claim 1, characterized in that: The recombinant genetic engineering bacteria does not contain the following genes: sphingosine kinase phosphate LCB4 gene, ceramide synthase LAG1 gene and LAC1 gene, LDB16 gene, sphingolipid homeostasis protein orm1 gene and orm2 gene, L-serine deaminase CHA1 gene, L-serine hydroxymethyltransferase SHM1 gene and SHM2 gene, fatty acid elongation enzyme elo2 gene.

6. The recombinant genetically engineered bacterium according to any one of claims 1 to 5, characterized in that: The starting strain of the recombinant strain is Saccharomyces cerevisiae S288c.

7. The recombinant genetically engineered bacterium according to any one of claims 1 to 5, characterized in that: The transformation of the recombinant genetically engineered bacteria is accomplished using the CRISPR Cas9 yeast genome editing method.

8. Use of the recombinant genetically engineered bacteria according to any one of claims 1 to 7 in the production of phytosphingosine.

9. A method for producing phytosphingosine, characterized in that: It includes the following steps: The recombinant genetic engineering strain according to any one of claims 1 to 7 is inoculated into a YPD seed medium, cultured overnight at 25 to 30° C. and 100 to 200 rpm, transferred to a YPD fermentation medium, fermented for 4 to 10 days at 25 to 30° C. and 100 to 200 rpm, and after the fermentation is completed, the cells are collected by centrifugation, ground and crushed, and then extracted with methanol to obtain phytosphingosine; The seed culture medium and fermentation liquid are formulated as follows: 15-20 g / L of peptone, 5-10 g / L of yeast powder, 10-30 g / L of glucose, and the balance is water.

10. The method according to claim 9, characterized in that: The formula of the seeds and fermentation medium is: 20 g / L peptone, 10 g / L yeast powder, 20 g / L glucose, and the balance is water.

Citation Information

Patent Citations

  • Saccharomyces cerevisiae strain with high yield of phytosphingosine

    CN116103176A

  • Method for producing phytosphingosine or sphinganine

    US20180179562A1

Cited By

  • Streptococcus salivarius subsp. Thermophilus for producing phytosphingosine, preparation method and application

    CN120310714A